Laekna, Inc.

HK$6.05As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2105Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR (26.29%)
Div yield —
ROE (10.69%)
Biotechnology
Beta (5Y) (1.06)
PE TTM —
TSR TTM (48.55%)
Mkt cap HK$2.578B
ROIC (8.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.58
25.25%
43.58%
Hold 5|11|3|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.10
0.10
0.10
13.55%
19.86%
9.25%
4.38%
Revenue¥M
282.6
284.6
293.9
300.3
(2.06%)
1.20%
6.81%
11.57%
Peers (US$328.9M)
Cap (US$)
PE
386.6M
36.53x
353.6M
16.80x
Capital
TTM
5Y
10Y
Leveragex
1.459
0.059
0.052
EBIT/Intx
2.089
0.273
0.231
Own earn%
90.95
(266.95)
(258.24)
Sh yield%
34.76
43.30
38.40
Owners
Insiders/Inst%
3.53
70.25
Short interest%
5.56
SBC / revenue%
2.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
4–8
$1 testx
—
Incr. ROIC%
55